Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans
- PMID: 22389461
- PMCID: PMC3403866
- DOI: 10.1093/gerona/gls001
Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans
Abstract
Background. Studies of drug-related hospitalizations have focused on adverse drug reactions, but few data are available on therapeutic failures (TFs) and adverse drug withdrawal events (ADWEs) leading to hospitalization among community-dwelling older adults. Thus, we sought to describe the prevalence of unplanned hospitalizations caused by TFs and ADWEs. In addition, we evaluated factors associated with these events in a nationally representative sample of older Veterans. Methods. This study included 678 randomly selected unplanned hospitalizations of older (age ≥ 65 years) Veterans between December 1, 2003, and November 9, 2006. The main outcomes were hospitalizations caused by a TF and/or an ADWE as determined by a pair of health professionals from review of medication charts and application of the Therapeutic Failure Questionnaire and/or Naranjo ADWE algorithm, respectively. Preventability (ie, medication error) of the admission was also assessed. Results. Thirty-four TFs and eight ADWEs involving 54 drugs were associated with 40 (5.9%) Veterans' hospitalizations; of these admissions, 90.0% (36/40) were rated as potentially preventable mostly due to medication nonadherence and suboptimal prescribing. The most common TFs that occurred were heart failure exacerbations (n = 8), coronary heart disease symptoms (n = 6), tachyarrhythmias (n = 3), and chronic obstructive pulmonary disease exacerbations (n = 3). Half (4/8) of the ADWEs that occurred were cardiovascular in nature. Multivariable logistic regression modeling indicated that black Veterans (adjusted odds ratio 2.92, 95% CI 1.25-6.80) were significantly more likely to experience a TF-related admission compared with white Veterans. Conclusions. TF-related unplanned hospitalizations occur more frequently than ADWE-related admissions among older Veterans. Almost all TFs and/or ADWEs are potentially preventable.
Similar articles
-
Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans.J Am Geriatr Soc. 2012 Jan;60(1):34-41. doi: 10.1111/j.1532-5415.2011.03772.x. Epub 2011 Dec 8. J Am Geriatr Soc. 2012. PMID: 22150441 Free PMC article.
-
Adverse events after discontinuing medications in elderly outpatients.Arch Intern Med. 1997 Oct 27;157(19):2205-10. Arch Intern Med. 1997. PMID: 9342997
-
Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm.Int J Qual Health Care. 2012 Jun;24(3):239-49. doi: 10.1093/intqhc/mzs015. Epub 2012 Apr 11. Int J Qual Health Care. 2012. PMID: 22495574
-
Epidemiology of medication-related adverse events in nursing homes.Am J Geriatr Pharmacother. 2006 Sep;4(3):264-72. doi: 10.1016/j.amjopharm.2006.09.011. Am J Geriatr Pharmacother. 2006. PMID: 17062328 Review.
-
Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: A systematic review.PLoS One. 2022 Sep 23;17(9):e0275116. doi: 10.1371/journal.pone.0275116. eCollection 2022. PLoS One. 2022. PMID: 36149932 Free PMC article.
Cited by
-
Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.Eur J Clin Pharmacol. 2017 Jan;73(1):79-89. doi: 10.1007/s00228-016-2136-8. Epub 2016 Oct 4. Eur J Clin Pharmacol. 2017. PMID: 27704168
-
Assessment tool for hospital admissions related to medications: development and validation in older patients.Int J Clin Pharm. 2019 Feb;41(1):198-206. doi: 10.1007/s11096-018-0768-8. Epub 2018 Dec 26. Int J Clin Pharm. 2019. PMID: 30585296 Free PMC article.
-
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People.Pharmaceuticals (Basel). 2022 Aug 8;15(8):977. doi: 10.3390/ph15080977. Pharmaceuticals (Basel). 2022. PMID: 36015125 Free PMC article. Review.
-
Cooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy - the COOP Study: study protocol for a cluster randomised controlled trial.Trials. 2017 Apr 4;18(1):158. doi: 10.1186/s13063-017-1900-0. Trials. 2017. PMID: 28372591 Free PMC article. Clinical Trial.
-
Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review.J Am Geriatr Soc. 2025 Jun;73(6):1918-1928. doi: 10.1111/jgs.19457. Epub 2025 Mar 28. J Am Geriatr Soc. 2025. PMID: 40152210 Free PMC article.
References
-
- Mannesse CK, Derkx FH, de Ridder MA, Man in ‘t Veld AJ, van der Cammen TJ. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000;29(1):35–39. - PubMed
-
- Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46–54. - PubMed
-
- Handler SM, Wright RM, Ruby CM, Hanlon JT. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother. 2006;4(3):264–272. - PubMed
-
- Hanlon JT, Handler SM, Maher R, Schmader KE. Geriatric pharmacotherapy and polypharmacy. In: Fillit H, Rockwood K, Woodhouse K, editors. Brocklehurst’s Textbook of Geriatric Medicine. London, UK: Churchill Livingstone; 2010. pp. 880–885.
Publication types
MeSH terms
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- N01-AG-62101/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- N01-AG-62106/AG/NIA NIH HHS/United States
- R01HS018721/HS/AHRQ HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- N01-AG-62103/AG/NIA NIH HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous